Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Oncocyte Corp (NQ: OCX )

3.428 +0.208 (+6.46%)
Streaming Delayed Price Updated: 11:09 AM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Oncocyte Corp

Oncocyte's VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier
Via ACCESSWIRE
Oncocyte to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
Via ACCESSWIRE
Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage
Via ACCESSWIRE
Oncocyte Reports Second Quarter 2023 Financial Results
Via ACCESSWIRE
Oncocyte Regains Compliance With Nasdaq Listing Requirements
Via ACCESSWIRE
Oncocyte to Participate in 8th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference
Via ACCESSWIRE
Oncocyte To Announce Second Quarter 2023 Financial Results
Via ACCESSWIRE
EchelonDx and Oncocyte Announce Collaboration to Create Seamless Informatics Software to Scale Proprietary Clinical Test Offerings
From Echelon Diagnostics, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.